论文部分内容阅读
目的探讨充血性心力衰竭(CHF)并室性心律失常(VA)的临床意义及药物治疗原则。方法108例CHF并VA患者根据治疗方法不同分为A、B、C三组,A组常规抗心衰治疗。B组加用Ⅰc美抗心律失常药物(心律平)。C组加用Ⅲ类抗心律失常药物(胺碘翻)。结果三组心律失常控制总有效率分别为87.5%、89.3%、89.7%,无显著性盖异(P>0.05),心功能改善总有效率分别为92.5%、61.8%、94.1%。结论CHF并发VA与心衰程度有关,抗心律失常药物治疗胺碘酮明显优于心律平。
Objective To investigate the clinical significance of congestive heart failure (CHF) and ventricular arrhythmia (VA) and the principle of drug therapy. Methods One hundred and eight patients with CHF and VA were divided into three groups according to different treatment methods: A, B and C, A group were treated with conventional anti-heart failure. Group B plus Ic anti-arrhythmic drugs (rhythm). Group C plus class III anti-arrhythmic drugs (amine iodine turned). Results The total effective rate of arrhythmia control in the three groups was 87.5%, 89.3% and 89.7% respectively. There was no significant difference (P> 0.05). The total effective rate of heart function improvement was 92.5%, 61.8% and 94.1% respectively. Conclusion Concurrent CHF with CHF is related to the degree of heart failure. Antiarrhythmic drug treatment of amiodarone is obviously better than that of heart rate.